Literature DB >> 27365149

Absence of Basal Cell Carcinoma in Irradiated Childhood Cancer Survivors of Black Race: A Report from the St. Jude Lifetime Cohort Study.

Matthew J Ehrhardt1, Nickhill Bhakta2, Qi Liu3, Yutaka Yasui4, Matthew J Krasin5, Daniel A Mulrooney1, Melissa M Hudson1, Leslie L Robison6.   

Abstract

BACKGROUND: Cancer survivors exposed to therapeutic radiation are at increased risk for basal cell carcinoma (BCC). Despite the notable influence of race on rates of BCC in the general population, the same is not clearly defined in previously irradiated cancer survivors. We investigated the influence of race on the development of BCC in adult survivors of childhood cancer.
METHODS: Using a retrospective cohort study, outcomes were collected through June 30, 2015, for 1,746 irradiated childhood cancer survivors participating in the St. Jude Lifetime Cohort Study (SJLIFE), comprising a total of 33,147 person-years of follow-up. Subsequent neoplasms identified in survivors through self-report and prospective clinical assessment were validated by pathology reports. Expected numbers of each type of radiation-associated neoplasm, including BCC, were calculated for irradiated black survivors based on rates in irradiated white survivors, accounting for primary cancer diagnosis, diagnosis year, attained age, and sex.
RESULTS: On the basis of the rate of BCC in previously irradiated white survivors, 56.1 BCCs were expected among 237 black survivors, yet none observed. In contrast, the observed-to-expected ratio of non-BCC radiation-associated neoplasms (melanoma, brain, breast, thyroid cancer) was 0.88 (30 observed/34.2 expected, 95% confidence interval, 0.59-1.25).
CONCLUSIONS: We identified an unexpected absence of BCC in irradiated black survivors in SJLIFE. We observe a similar absence of BCC in black individuals among two additional cohorts treated with irradiation for childhood cancer. IMPACT: Black survivors are at a substantially reduced or absent risk for BCC from therapeutic radiation for reasons not yet fully understood. Cancer Epidemiol Biomarkers Prev; 25(9); 1356-60. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27365149      PMCID: PMC5010444          DOI: 10.1158/1055-9965.EPI-16-0280

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  31 in total

1.  Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.

Authors:  M R Karagas; J A McDonald; E R Greenberg; T A Stukel; J E Weiss; J A Baron; M M Stevens
Journal:  J Natl Cancer Inst       Date:  1996-12-18       Impact factor: 13.506

Review 2.  Epidemiology of basal cell carcinoma.

Authors:  Valquiria Pessoa Chinem; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2011 Mar-Apr       Impact factor: 1.896

3.  Basal-cell carcinomas on the scalp of a black patient many years after epilation by x rays.

Authors:  R R Walther; M E Grossman; J L Troy
Journal:  J Dermatol Surg Oncol       Date:  1981-07

4.  Cancer incidence among medical diagnostic X-ray workers in China, 1950 to 1985.

Authors:  J X Wang; P D Inskip; J D Boice; B X Li; J Y Zhang; J F Fraumeni
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

5.  Early and late survival in Hodgkin disease among whites and blacks living in the United States.

Authors:  A Zaki; N Natarajan; C J Mettlin
Journal:  Cancer       Date:  1993-07-15       Impact factor: 6.860

6.  Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.

Authors:  R S Stern; L A Thibodeau; R A Kleinerman; J A Parrish; T B Fitzpatrick
Journal:  N Engl J Med       Date:  1979-04-12       Impact factor: 91.245

7.  Undifferentiated sinonasal carcinoma in a patient with nevoid basal cell carcinoma syndrome.

Authors:  Amy Sobota; Maria Pena; Mariarita Santi; Atif Ali Ahmed
Journal:  Int J Surg Pathol       Date:  2007-07       Impact factor: 1.271

8.  Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.

Authors:  Silje Haukali Omland; Robert Gniadecki; Merete Hædersdal; Jannik Helweg-Larsen; Lars Haukali Omland
Journal:  JAMA Dermatol       Date:  2016-02       Impact factor: 10.282

9.  Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study.

Authors:  Joanna L Perkins; Yan Liu; Pauline A Mitby; Joseph P Neglia; Sue Hammond; Marilyn Stovall; Anna T Meadows; Ray Hutchinson; Zoann E Dreyer; Leslie L Robison; Ann C Mertens
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 50.717

10.  Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Authors:  Debra L Friedman; John Whitton; Wendy Leisenring; Ann C Mertens; Sue Hammond; Marilyn Stovall; Sarah S Donaldson; Anna T Meadows; Leslie L Robison; Joseph P Neglia
Journal:  J Natl Cancer Inst       Date:  2010-07-15       Impact factor: 11.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.